Teyi Pharmaceutical Group Co.,Ltd
Shenzhen Stock Exchange 002728.SZ
Teyi Pharmaceutical Group Co.,Ltd Operating Cash Flow for the year ending December 31, 2023: USD 27.97 M
-
Teyi Pharmaceutical Group Co.,Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 53.86 M, a 33.25% change year over year.
-
Teyi Pharmaceutical Group Co.,Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 40.42 M, a 56.12% change year over year.
-
Teyi Pharmaceutical Group Co.,Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 25.89 M, a -18.66% change year over year.
-
Teyi Pharmaceutical Group Co.,Ltd Operating Cash Flow for the year ending December 31, 2019 was USD 31.83 M, a 16.46% change year over year.
| Date | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid |
|---|
| CEO | Mr. Songqing Xu |
| IPO Date | July 31, 2014 |
| Location | China |
| Headquarters | No. 9, 11, Changxing Road |
| Employees | 1,243 |
| Sector | Health Care |
| Industries | |
Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China.
Past 5 years
USD 2.18
USD 2.72
USD 0.24
USD 1.72
USD 2.26
StockViz Staff
January 15, 2025
Any question? Send us an email